| Quarterly Financials | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 |
| Revenue | 80 | 104 | 80 | 100 | 108 | 117 | 134 | 159 |
| Expenses | 64 | 80 | 59 | 77 | 77 | 95 | 104 | 112 |
| EBITDA | 16 | 24 | 21 | 23 | 31 | 22 | 30 | 47 |
| Operating Profit % | 19 % | 22 % | 26 % | 21 % | 25 % | 10 % | 20 % | 27 % |
| Depreciation | 3 | 4 | 4 | 4 | 4 | 5 | 6 | 8 |
| Interest | 3 | 3 | 5 | 5 | 6 | 5 | 5 | 6 |
| Profit Before Tax | 10 | 18 | 14 | 16 | 21 | 21 | 27 | 41 |
| Tax | 3 | 3 | 3 | 3 | 4 | 3 | 5 | 11 |
| Net Profit | 7 | 14 | 11 | 13 | 16 | 18 | 21 | 30 |
| EPS in ₹ | 4.01 | 8.03 | 3.39 | 3.92 | 5.04 | 3.81 | 4.60 | 6.54 |











Bank of India Multi Cap Fund Direct-Growth
Bandhan BSE Healthcare Index Fund Direct-Growth
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
Mahindra Manulife Balanced Advantage Fund Direct - Growth 
